Illumina (ILMN)- Daniel Bradbury, Director, sold 600 shares at $168.42. The total value of the transaction was $101,053. Bradbury still owns 16,465 shares of ILMN.
Xenon Pharmaceuticals (XENE)- Frank A. Holler, Director, sold 18,062 shares in three separate transactions. Holler sold 6,863 shares at $8.25; 1,600 shares at $7.89; and 9,599 shares at $7.70. Holler still owns 157,807 shares of XENE.
SciClone Pharmaceuticals (SCLN)- Friedhelm Blobel, President & CEO, sold 501,875 shares at $10. The total value of the transaction was approximately $5.02 million. Blobel still owns 86,380 shares of SCLN.
Xencor (XNCR)- Basil I Dahiyat, President & CEO, sold 45,886 shares at $22.06. The total value of the transaction was approximately $1.01 million. Dahiyat still owns 381,128 shares of XNCR.